Log in to save to my catalogue

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease a...

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c2224b70b0984cf8addb329a11427562

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals

About this item

Full title

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals

Publisher

England: BioMed Central Ltd

Journal title

Translational Neurodegeneration, 2021-03, Vol.10 (1), p.11-11, Article 11

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The development of in vivo biomarkers of Alzheimer's disease (AD) has advanced the diagnosis of AD from a clinical syndrome to a biological construct. The preclinical stage of AD continuum is defined by the identification of AD biomarkers crossing the pathological threshold in cognitively unimpaired individuals. While neuropsychiatric symptoms (NPS...

Alternative Titles

Full title

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c2224b70b0984cf8addb329a11427562

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c2224b70b0984cf8addb329a11427562

Other Identifiers

ISSN

2047-9158

E-ISSN

2047-9158

DOI

10.1186/s40035-021-00236-3

How to access this item